Antonio Alcaraz

Publicacions destacades

• Prognostic classifier for predicting biochemical recurrence in localized prostate cancer patients after radical prostatectomy

  Autors: Carrion A, Ingelmo-Torres M, Lozano JJ, Montalbo R, D'Anna M, Mercader C, Velez E, Ribal MJ, Alcaraz A, Mengual L .

  Referència: Urologic Oncology-Seminars And Original Investigations 2021.

• Robot-assisted kidney transplantation: update from the European Robotic Urology Section (ERUS) series

  Autors: Musquera M, Peri L, Ajami T, Campi R, Tugcu V, Decaestecker K, Stockle M, Fornara P, Doumerc N, Vigues F, Barod R, Desender L, Territo A, Serni S, Vignolini G, Sahin S, Zeuschner P, Banga N, Breda A, Alcaraz A .

  Referència: Bju International 2021.

• Learning Curve in Robot-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group

  Autors: Gallioli A, Territo A, Boissier R, Campi R, Vignolini G, Musquera M, Alcaraz A, Decaestecker K, Tugcu V, Vanacore D, Serni S, Breda A .

  Referència: European Urology 2020.

• Urine cytology suspicious for urothelial carcinoma: Prospective follow-up of cases using cytology and urine biomarker-based ancillary techniques

  Autors: Montalbo, Ruth; Izquierdo, Laura; Ingelmo-Torres, Mercedes; Galve, Pilar; Sole, Manel; Franco, Agustin; Jose Ribal, Maria; Alcaraz, Antonio; Mengual, Lourdes;.

  Referència: Cancer Cytopathology 2020.

• Urine Gene Expression Profiles in Bladder Pain Syndrome Patients Treated with Triamcinolone

  Autors: Izquierdo L; Mateu L; Lozano JJ; Montalbo R; Ingelmo-Torres M; Gómez A; Peri L; Mengual L; Franco A; Alcaraz A.

  Referència: European Urology Focus 2020.

• The Role of Fluorescence in Situ Hybridization for Predicting Recurrence after Adjuvant Bacillus Calmette-Guérin in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer Patients: A Systematic Review and Meta-Analysis of Individual Patient Data

  Autors: Liem EIML, Oddens JR, Vernooij RWM, Li R, Kamat A, Dinney CP, Mengual L, Alcaraz A, Izquierdo L, Savic S, Thalmann GN, Bubendorf L, Sylvester RJ, de Reijke TM .

  Referència: Journal Of Urology 2020.

• INCOMPATIBILITY LIVING DONOR KIDNEY TRANSPLANT, WHERE ABO INCOMPATIBLE, POSITIVE CROSSMATCH AND KIDNEY PAIRED DONATION TRANSPLANTS HAVE A PLACE!

  Autors: Revuelta, Ignacio; De Sousa-Amorim, Erika; Cucchiari, David; Lozano, Miguel; Musquera, Mireia; Palou, Eduard; Valentin, Maria O.; Ventura-Aguiar, Pedro; Cid, Joan; Martorell, Jaume; Peri, Lluis; Garcia, Marta; Esforzado, Nuria; Cofan, Frederic; Vicente Torregrosa, Jose; Julio Pineiro, Gaston; Ugalde-Altamirano, Jessica; Paredes, David; Adalia, Ramon; Campistol, Josep M.; Alcaraz, Antonio; Oppenheimer, Federico; Diekmann, Fritz;.

  Referència: Transplant International 2019.

• Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients

  Autors: Montalbo R, Lozano JJ, Izquierdo L, Ingelmo-Torres M, BaÑos C, Palou J, Van der Heijden AG, Medina R, Schmidbauer J, Prat A, Ribal MJ, Alcaraz A, Mengual L .

  Referència: Translational Research 2019.

• Germline variation at 8q24 and prostate cancer risk in men of European ancestry

  Autors: Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, Schumacher FR, Ingles SA, Govindasami K, Benlloch S, Berndt SI, Albanes D, Koutros S, Muir K, Stevens VL, Gapstur SM, Tangen CM, Batra J, Clements J, Gronberg H, Pashayan N, Schleutker J, Wolk A, West C, Mucci L, Kraft P, Cancel-Tassin G, Sorensen KD, Maehle L, Grindedal EM, Strom SS, Neal DE, Hamdy FC, Donovan JL, Travis RC, Hamilton RJ, Rosenstein B, Lu YJ, Giles GG, Kibel AS, Vega A, Bensen JT, Kogevinas M, Penney KL, Park JY, Stanford JL, Cybulski C, Nordestgaard BG, Brenner H, Maier C, Kim J, Teixeira MR, Neuhausen SL, De Ruyck K, Razack A, Newcomb LF, Lessel D, Kaneva R, Usmani N, Claessens F, Townsend PA, Gago-Dominguez M, Roobol MJ, Menegaux F, Khaw KT, Cannon-Albright LA, Pandha H, Thibodeau SN, Schaid DJ,, Wiklund F, Chanock SJ, Easton DF, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium.

  Referència: Nature Communications 2018.

• Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

  Autors: Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, Sheng X, Zhang Z, Muir K, Govindasami K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman P, Thompson IM, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger G, Gronberg H, Aly M, Nordström T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, Hakansson N, West C, Dunning AM, Burnet N, Mucci L, Giovannucci E, Andriole G, Cussenot O, Cancel-Tassin G, Koutros S, Freeman LEB, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein B, Kerns S, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, Gómez-Caamaño A, Fachal L, Szulkin R, Eklund M, Kogevinas M, Llorca J, Castaño-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weisher M, Bisbjerg R, Røder MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Slavov C, Mitev V, Parliament M, Singhal S, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Kierzek A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Kraft P,, Freedman M, Wiklund F, Chanock S, Henderson BE, Easton DF, Haiman CA, Eeles RA, Conti DV, Kote-Jarai Z PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium.

  Referència: Nature Communications 2018.